The Influence of Tumor Immune Microenvironment and Tumor Immunity on the Pathogenesis, Treatment and Prognosis of Post-Transplant Lymphoproliferative Disorders (Ptld)

Hematological Oncology- United Kingdom

doi 10.1002/hon.15_2630

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

Post-Transplant Lymphoproliferative Disease – PTLD

2012English

Baseline Differential Blood Count and Prognosis in CD20-positive Post-Transplant Lymphoproliferative Disorder in the Prospective PTLD-1 Trial

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

Management of Post-Transplant Lymphoproliferative Disorders

British Journal of Haematology
Hematology
2018English

Post-Transplant Lymphoproliferative Disorders: From Treatment to Early Detection and Prevention?

Haematologica
Hematology
2007English

Modification of the Tumor Microenvironment to Enhance Immunity

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2007English

Multiplexed Imaging Characterizes the Tumor–Immune Microenvironment

Cancer Discovery
Oncology
2018English

Mutational Landscape of B-Cell Post-Transplant Lymphoproliferative Disorders

British Journal of Haematology
Hematology
2017English

P3.03-26 Tumor Immune Microenvironment in NSCLC Is Predictive of Prognosis After Surgery

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy

Frontiers in Immunology
AllergyImmunology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy